Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.

S.L.W. Koolen; R.L. Oostendorp; J.H. Beijnen; J.H.M. Schellens; A.D.R. Huitema

doi:10.1111/j.1365-2125.2010.03621.x

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.

S.L.W. Koolen
, R.L. Oostendorp
, J.H. Beijnen
, J.H.M. Schellens
, A.D.R. Huitema

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	465-474
Number of pages	10
Journal	British Journal of Clinical Pharmacology
Volume	69
Issue number	5
DOIs	https://doi.org/10.1111/j.1365-2125.2010.03621.x
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/j.1365-2125.2010.03621.x

Cite this

@article{b06d4ea751404e32b2f3c1b42b9ea1ad,

title = "Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.",

author = "S.L.W. Koolen and R.L. Oostendorp and J.H. Beijnen and J.H.M. Schellens and A.D.R. Huitema",

year = "2010",

doi = "10.1111/j.1365-2125.2010.03621.x",

language = "English",

volume = "69",

pages = "465--474",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer. / Koolen, S.L.W.; Oostendorp, R.L.; Beijnen, J.H. et al.
In: British Journal of Clinical Pharmacology, Vol. 69, No. 5, 2010, p. 465-474.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.

AU - Koolen, S.L.W.

AU - Oostendorp, R.L.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

AU - Huitema, A.D.R.

PY - 2010

Y1 - 2010

U2 - 10.1111/j.1365-2125.2010.03621.x

DO - 10.1111/j.1365-2125.2010.03621.x

M3 - Article

SN - 0306-5251

VL - 69

SP - 465

EP - 474

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 5

ER -